These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 23017938)

  • 1. Integrative physiology of depression and antidepressant drug action: implications for serotonergic mechanisms of action and novel therapeutic strategies for treatment of depression.
    Hale MW; Raison CL; Lowry CA
    Pharmacol Ther; 2013 Jan; 137(1):108-18. PubMed ID: 23017938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond serotonin.
    Meltzer HY
    J Clin Psychiatry; 1991 May; 52 Suppl():58-62. PubMed ID: 2030105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression.
    Blier P; de Montigny C; Chaput Y
    J Clin Psychopharmacol; 1987 Dec; 7(6 Suppl):24S-35S. PubMed ID: 3323264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glatiramer acetate could be a potential antidepressant through its neuroprotective and anti-inflammatory effects.
    Tsai SJ
    Med Hypotheses; 2007; 69(1):145-8. PubMed ID: 17196755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic properties of serotonergic agents and antidepressant drugs.
    Fuller RW
    J Clin Psychiatry; 1987 Mar; 48 Suppl():5-11. PubMed ID: 3493240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment resistant depression as a failure of brain homeostatic mechanisms: implications for deep brain stimulation.
    Giacobbe P; Mayberg HS; Lozano AM
    Exp Neurol; 2009 Sep; 219(1):44-52. PubMed ID: 19426730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. History and evolution of the monoamine hypothesis of depression.
    Hirschfeld RM
    J Clin Psychiatry; 2000; 61 Suppl 6():4-6. PubMed ID: 10775017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Putative role of endocannabinoid signaling in the etiology of depression and actions of antidepressants.
    Gorzalka BB; Hill MN
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1575-85. PubMed ID: 21111017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic armamentarium for treating depression.
    Howland RH
    Postgrad Med; 2010 Jul; 122(4):66-93. PubMed ID: 20675972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of neurotransmitter receptors by desipramine and other antidepressant drugs: the neurotransmitter receptor hypothesis of antidepressant action.
    Stahl SM
    J Clin Psychiatry; 1984 Oct; 45(10 Pt 2):37-45. PubMed ID: 6090439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanisms.
    Bschor T; Lewitzka U; Sasse J; Adli M; Köberle U; Bauer M
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S230-4. PubMed ID: 14677084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Animal models of depression: challenges from a drug development perspective.
    Rupniak NM
    Behav Pharmacol; 2003 Sep; 14(5-6):385-90. PubMed ID: 14501252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The serotonin concept of depression in light of the mechanism of action of antidepressant drugs].
    Kostowski W; Płaźnik A
    Psychiatr Pol; 1989; 23(2):117-24. PubMed ID: 2682712
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhancement of the 5-HT neurotransmission by antidepressant treatments.
    De Montigny C
    J Physiol (Paris); 1981; 77(2-3):455-61. PubMed ID: 6270317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New approaches to the pharmacological management of major depressive disorder.
    Witkin JM; Li X
    Adv Pharmacol; 2009; 57():347-79. PubMed ID: 20230766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major depressive disorder: remission of associated symptoms.
    Trivedi MH
    J Clin Psychiatry; 2006; 67 Suppl 6():27-32. PubMed ID: 16848674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
    Akiskal HS; Benazzi F; Perugi G; Rihmer Z
    J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological basis of depression and therapeutic relevance.
    Richelson E
    J Clin Psychiatry; 1991 Jun; 52 Suppl():4-10. PubMed ID: 1646793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Personality factors in depressive disorders: contribution of the psychobiologic model developed by Cloninger].
    Pelissolo A; Corruble E
    Encephale; 2002; 28(4):363-73. PubMed ID: 12232546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for a biochemical lesion in depression.
    Leonard BE
    J Clin Psychiatry; 2000; 61 Suppl 6():12-7. PubMed ID: 10775019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.